NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/25/2025
Back to search
Official data from USPTO
SPECTRA-SCOPE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SPECTRA-SCOPE
ST13
US500000087509554Class
10
Filing
87509554
Registration
5778414
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
01/25/2025
Trademark type
Word
Nice classes
10
Filing date
06/28/2017
Registration date
06/18/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/25/2025
Last transaction
01/25/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Seoul, KR
Examiner
ROSEN, AMANDA
Current location
Historical data usage
Holders and representatives
Holders
Speclipse, Inc.
Representatives
Kisuk Lee HARNESS DICKEY & PIERCE PLC
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical apparatuslaser devicesspectrometersprobes for medical detection of benign lesionsmalignant lesions and dermatological diseases; Medical analysis apparatusprobes for analyzing benign lesionsmalignant lesions and dermatological diseases; Medical diagnostic apparatuslaser diagnostic and imaging apparatus for non-invasive measurement of tissue alterations; Medical imaging apparatus for use in clinical imaging and diagnosis; Medical diagnostic apparatuslaser diagnostic and imaging apparatusultrasonic diagnostic and imaging apparatus; Imaging apparatus for medical and surgical purposes for use in clinical diagnosis; Medical optical diagnostic apparatus for testing benign lesionsmalignant lesions and dermatological diseasesfor use in clinical diagnosis ; Optical laser scanners for medical and surgical purposes; Laser handpiece for medical purposesdermatological purposes
Publications
History of USPTO decisions and trademark events.
31 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/25/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/25/2025
E815
TEAS SECTION 8 & 15 RECEIVED
09/06/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/18/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2019
TMBN
TTAB RELEASE CASE TO TRADEMARKS
02/06/2019
OP.T
OPPOSITION TERMINATED NO. 999999
02/06/2019
OP.D
OPPOSITION DISMISSED NO. 999999
02/06/2019
OP.I
OPPOSITION INSTITUTED NO. 999999
11/12/2018
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/13/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/15/2018
PUBO
PUBLISHED FOR OPPOSITION
05/15/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/25/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/12/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2018
ALIE
ASSIGNED TO LIE
03/26/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/13/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/31/2017
GNSL
LETTER OF SUSPENSION E-MAILED
10/31/2017
CNSL
SUSPENSION LETTER WRITTEN
10/31/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/30/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/28/2017
GNRT
NON-FINAL ACTION E-MAILED
09/28/2017
CNRT
NON-FINAL ACTION WRITTEN
09/28/2017
DOCK
ASSIGNED TO EXAMINER
09/25/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/06/2017
NWAP
NEW APPLICATION ENTERED
07/01/2017
Continuous trademark protection
Get notified about every new filing that threatens SPECTRA-SCOPE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.